Cerapedics Gains Canadian Approval of Next-Gen Bone Graft

Cerapedics announced Health Canada approval of their next-generation bone graft called i-FACTOR®+ Matrix, making it the first market to approve the commercial launch of this product. Product launch will commence in 4Q20.

The technology is currently being studied in an FDA Investigational Device Exemption (IDE) study, ASPIRE, targeting...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us